The human hepatocyte growth factor ELISA test (human HGF) quantifies human HGF in serum, plasma, cell culture supernatants or other human body fluids. The dosage will recognize exclusively HGF...
The human hepatocyte growth factor ELISA test (human HGF) quantifies human HGF in serum, plasma, cell culture supernatants or other human body fluids. The dosage will only recognize natural and recombinant human HGF. Principle of the L-ELISA solid phase sandwich method for human HGF (immuno-enzymatic test) is designed to measure the amount of the target bound between a pair of matched antibodies. A target-specific antibody was pre-vested in the wells of the supplied microplate. Samples or controls are then added to these wells and are linked to immobilized antibodies (capture). The sandwich is formed by binding the second antibody (detector) to the target on a different epitope from the capture antibody. An antibody conjugated with the enzyme binds the formed sandwich. After incubation and washing steps to remove the microplate from the non-bonded substances, a substrate solution reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this coloured product is directly proportional to the concentration of TP (p) present in the original sample. Rigorous validation Each batch manufactured from this ELISA kit is tested for quality for criteria such as sensitivity, specificity, accuracy and batch-to-batch consistency. See the product manual for more information on validation.
Hepatocyte growth factor (HGF) is a member of the plasminogenic subfamily of peptidases S 1. The inactive polypeptide formed during translation undergoes cleavage to produce an alpha 69 kDa chain and a beta 34 kDa chain. A disulfide bond between the two chains makes HGF active. HGF is secreted by mesenchymatous cells and stimulates mitogenesis, cell motility and matrix invasion. It is involved in cell growth and morphogenesis in a wide variety of tissue types. In humans, HGF is present on chromosome 7.
Sensitivity
Sensitivity of the dosage: 5.5 pg/ml.
Measurement range
Dose range: 63-4.000 pg/ml.
Duration of dosing
Total duration of dosing: 3 h 10 min.
Reproducibility
Coefficient of variation intra-dose 7.6%, inter-dose 8.3%.
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 15511587 |
| Specifications |
| Accession number | P14210 |
| Dose range | 63-4.000 pg/ml |
| Sensitivity of the dosage | 5.5 pg/ml |
| Conjugate | Biotin |
| Product type | Kit ELISA |
| Type of sample | Serum, Surnatant, Supernatant |
| Target species | Human |
| For use with (application) | ELISA |
| For use with (equipment) | Colorimetric microplate reader |
| Genetic identification (Enter) | 3082 |
| Gene symbol(s) | DFNB39,F-TCFB,HPTA,SF,HGF |
| Coefficient of inter-dose variation | 8.3% |
| Coefficient of intra-dose variation | 7.6% |
| Contents of kits | 96-well pre-coated microplate, Biotinylated detection antibody, Sample diluent, Sample diluent, Standard curve strip, Standard curve strip, Wash buffer concentrate, Stop solution, Stop solution, Adhesive plate covers, Adhesive plate covers |
| Marker or dye | HRP |
| Quantity | 128 Tests |
| Regulatory status | RUO |
| Synonym | Hepatocyte growth factor, hepapoietin A, F-TCF |
| Target | Human |
| Test time | 20 min |
| Physical characteristics |
| Volume of sample | Plasma, 50 μl; Serum, 50 μl; Supernatant, 50 μl |
| Storage and shipping |
| Storage conditions | -20°C |
| Total duration of dosing | 3 h 10 min |
Origin and customs
| Manufacturer ref. | BMS2069INST |
|---|
| Country of origin | Autriche |
|---|
| HS customs code | 3002 15 00 00 |
|---|
A question or a specific configuration?
Contact us for a quote.